GlassScriptPhysician profile
Angelia Lovins
NPI 1265715163
$2,019.56
in general payments reported to CMS, 2019-2025
19 companies · $1,369 in 2025
The $1,369 reported for 2025 was more than what 91% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $159 · 2022: $231 · 2023: $245 · 2024: $14.92 · 2025: $1,369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $932 · Food and Beverage: $698.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $931.50 |
| Food and Beverage | $697.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $1,274.45 | 2025 | 3m Cavilon, Activ.A.C., Kerramax Care |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $109.71 | 2021-2022 | |
| Abbvie INC. | $96.00 | 2022-2023 | |
| Vertos Medical, INC. | $81.26 | 2023 | Mild Device Kit |
| Boston Scientific Corporation | $75.64 | 2022-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $75.58 | 2025 | Entyvio, Eohilia |
| Scilex Pharmaceuticals INC. | $51.61 | 2022-2023 | Ztlido |
| Pacira Therapeutics, INC. | $39.73 | 2021 | |
| Medtronic, INC. | $39.57 | 2021-2023 | Intellis Adaptivestim |
| Abbott Laboratories | $24.54 | 2022 | |
| Mml US, INC. | $20.79 | 2023 | Reactiv8 |
| Arbor Pharmaceuticals, INC. | $19.61 | 2021 | |
| Reapplix INC. | $19.35 | 2025 | 3c Patch Kit - Box |
| Novo Nordisk INC | $16.87 | 2023 | Wegovy |
| Biodelivery Sciences International, INC. | $16.85 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $16.58 | 2022 | |
| Lilly USA, LLC | $14.50 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $14.06 | 2022 | |
| Medline Industries LP | $12.86 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angelia Lovins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.